Mirabegron improves the irritative symptoms caused by BCG immunotherapy after transurethral resection of bladder tumors-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Mirabegron improves the irritative symptoms caused by BCG immunotherapy after transurethral resection of bladder tumors

Published:2021-09-21 Issue:21 Volume:10 Page:7534-7541
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Sun Kai¹^ORCID,Wang Di¹,Wu Gang¹,Ma Jian¹,Wang Tianqi¹,Wu Jitao¹,Wang Jipeng¹

Affiliation:

1. Department of Urology The Affiliated Yantai Yuhuangding Hospital of Qingdao University Yantai Shandong China

Publisher

Wiley

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.4278

Reference37 articles.

1. Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends

2. EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016

3. Clinical model of lifetime cost of treating bladder cancer and associated complications

4. Transurethral resection of the bladder tumour (TURBT) for non-muscle invasive bladder cancer: Basic skills

5. Intravesical Bacillus Calmette-Guerin Reduces the Risk of Progression in Patients with Superficial Bladder Cancer: A Meta-analysis of the Published Results of Randomized Clinical Trials

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. BCG induced lower urinary tract symptoms during treatment for NMIBC—Mechanisms and management strategies;Frontiers in Neuroscience;2024-01-08

2. Impact of Overactive Bladder on Quality of Life for Cancer Survivors;Current Bladder Dysfunction Reports;2023-08-24

3. Swedish National Guidelines on Urothelial Carcinoma: 2021 update on non-muscle invasive bladder cancer and upper tract urothelial carcinoma;Scandinavian Journal of Urology;2022-02-28

4. Effects of Buzhong Yiqi Decoction Combined with THP Bladder Perfusion on Postoperative Efficacy in Patients with Bladder Cancer;Evidence-Based Complementary and Alternative Medicine;2021-11-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3